Conference
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Investigational Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naive Adults 18-64 Years of Age with Increased Risk for Pneumococcal Disease
Authors
Scott P; Pathirana J; Kato A; Tytus R; Perez C; Gilchrist NL; Kanou H; Yoo KH; Kania G; Nissen M
Volume
58
Pagination
pp. S17-S17
Publisher
SPRINGER HEIDELBERG
Publication Date
April 1, 2025
Conference proceedings
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
ISSN
0948-6704